Study: Low-intensity warfarin has post-THA benefits

05/17/2013 | Healio

Treating patients with low-intensity warfarin for six weeks before total hip arthroplasty was associated with low incidence of bleeding and symptomatic venous thromboembolism in the next three months, according to a study in the journal Thrombosis Research. "Low-intensity warfarin should be considered in future studies to identify the regimen that optimally balances risk of bleeding and symptomatic venous thromboembolism in a real world setting," the authors concluded.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC